article · Mechanisms of Ageing and Development

Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer’s potential against amyloid-beta1–42-induced neurodegeneration

Mehdi Alami
Olaf van Tellingen
Ton Bunt
Hicham Berrougui
Abdelouahed Khalil
Kaoutar Boumezough
Abdelouahed Khalil
Hicham Berrougui
Benoit Laurent
Ikram Salih
Khalid Sadki
Tamas Fulop

2026Université Sultan Moulay Slimane

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Alzheimer's disease research and treatments
HIV Research and Treatment
Tryptophan and brain disorders

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.mad.2026.112161

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.